Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Ipilimumab induced digital vasculitis

Fig. 3

(Panel a and b) This picture was taken nine weeks after her second Ipilimumab infusion (week 31 on timeline). The patient is status-post high dose steroids and four cycles of Rituximab. The exam appeared worse with dry gangrene of the fingertips, secondary to the natural evolution of skin changes with distal digital ischemia. We believe that the vasculitic process was halted, as she did not develop further proximal digital ischemia

Back to article page